CIK 0001388320
- Non-accelerated filer
- Smaller reporting company
Actinium Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ATNM
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 880378336
- Phone
- +1 646-677-3870
- Business address
- 100 PARK AVE., 23RD FLOOR, NEW YORK, NY, 10017
- Former names
- Cactus Ventures, Inc.
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chairman & CEO bought 33,333 shares at $0.75 ($25,000)
- 4 Open-market buy Executive Vice President bought 10,000 shares at $0.75 ($7,500)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Chief Medical Officer bought 5,000 shares at $1.11 ($5,550)
- 4 Open-market buy Chairman and CEO bought 7,500 shares at an average $1.16 ($8,725)
- 4 Open-market buy Principal Financial Officer bought 3,500 shares at $1.17 ($4,095)
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Executive Chairman bought 5,000 shares at $0.88 ($4,400)
- 4 Open-market buy Executive Chairman bought 5,000 shares at $0.98 ($4,900)
- 4 Open-market sale 10% owner sold 192,927 shares at an average $1.83 ($352,372)
- 4 Open-market sale 10% owner sold 50,000 shares at an average $1.71 ($85,495)
Page 5 of 8 · 146 filings